Radel A. Sadykov

Radel A. Sadykov

Auto-generated profile, based on publicly available information

Radel A. Sadykov

Burdenko Neurosurgical Center

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2024 in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
Verified
Journal Article
Closed access
VSV. N. Shimansky
V. N. Shimansky
MKM. V. Kolycheva
M. V. Kolycheva
RSR. A. Sadykov
R. A. Sadykov
LSL. A. Sidneva
L. A. Sidneva
IKI. O. Kugushev
I. O. Kugushev
Glossopharyngeal neuralgia (GPN) is a rare disease (incidence of 16 cases per 10 000 000 population, i.e. about 50 times less frequent than trigeminal neuralgia). Glossopharyngeal neuralgia is characterised by recurrent stereotyped unilateral painful attacks in the area of the palatine tonsil, root of the tongue and the lateral part of the pharynx, irradiating to the ear. It is often precipitated by talking, swallowing and chewing movements, touching the zones of innervation of the IX nerve. Materials and Methods. From 2014 to the present, 12 patients with glossopharyngeal neuralgia were operated on at the Centre of Neurosurgery named after N. N. Burdenko. Women (7 women and 5 men) aged from 39 to 69 years (mean age 48 years) slightly prevailed in the study group. The intensity of pain syndrome was assessed by Visual Analogue Scale (VAS). All patients underwent preoperative brain MRI in FIESTA/CISS modes, as well as contrast-enhanced MRI of soft tissues of the neck, neurological examination, and otorhinolaryngological examination. Patients of the study group underwent microsurgical vascular decompression of the glossopharyngeal nerve withprotector placement through suboccipital retrosigmoid access. T welve patients were included in the catamnestic group. The periods of dynamic follow-up ranged from 1 month to 10 years (the average period was 5 years). Results. In the postoperative period complete regression of the pain syndrome was obtained in 92% of cases. In the remaining cases a significant reduction of the bulbar palsy according to the VAS scale was noted.In the postoperative period hearing reduction was revealed in 1 patient (8 %), in 2 patients there were coarse bulbar disorders (swallowing disorder, choking, feeling of a lump in the throat, coughing) (16 %). The most persistent character had acusia and bulbar disorders observed in the remote period. According to the data of the catamnestic study the positive result (regression of the pain syndrome) persisted in all patients. Conclusions. Vascular decompression is the only effective pathogenetic method of treatment of glossopharyngeal neuralgia, which relieves patients from debilitating pain syndrome. At the same time, bulbar palsy, which occur in some patients after the operation, are persistent, but subjectively bother patients to a much less extent than the initial pain syndrome.

8 July 2025 in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
Verified
Journal Article
Closed access
RSR. A. Sadykov
R. A. Sadykov
IKI. O. Kugushev
I. O. Kugushev
MKM. V. Kolycheva
M. V. Kolycheva
STS. V. Tanyashin
S. V. Tanyashin
VGV. A. Gorbulev
V. A. Gorbulev
VSV. N. Shimansky
V. N. Shimansky
Lingopharyngeal neuralgia (AGN) is a rare disease characterized by attacks of acute shooting pain in the pharynx, tonsils and root of the tongue, provoked by swallowing, speaking or eating. First described in 1910 by Weisenburg, YAGN remained a poorly understood pathology for a long time due to its rarity and complexity of diagnosis. A significant breakthrough in understanding its pathogenesis occurred in the 1920s thanks to the work of R. Sikar, W. Harris and A. Adson, which allowed them to lay the foundations of surgical treatment. Modern research links the disease to vasoneural conflict, and microvascular decompression (MVD), proposed by P. Janetta in 1977, has been recognized as an effective etiopathogenetic treatment method providing long-term remission. Despite the development of non-invasive approaches such as radiofrequency thermocoagulation and radiosurgery, their use is limited by high risks of complications. The article highlights the evolution of ideas about IAG, key historical stages in its study, and modern therapeutic and surgical strategies, emphasizing the need for further research to optimize diagnosis and treatment.

3 April 2026 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
VSV.N. Shimansky
V.N. Shimansky
LSL.A. Sidneva
L.A. Sidneva
STS.V. Tanyashin
S.V. Tanyashin
AOA.A. Ogurtsova
A.A. Ogurtsova
VPV.K. Poshataev
V.K. Poshataev
VGV.A. Gorbulev
V.A. Gorbulev
The annual incidence of hemifacial spasm is 8-15 cases per 100.000. This disease is not life-threatening, but it significantly impacts the quality of life. Primary treatment is vascular decompression of the facial nerve. Thus, improvement of appropriate technique is crucial for higher efficacy and safety. Objective. To determine the optimal algorithm for vascular decompression according to available international experience in surgical treatment of hemifacial spasm. Material and methods. A systematic review was conducted in accordance with the PRISMA guidelines. To identify relevant publications, we screened the PubMed, Google Scholar, and eLibrary databases through October 2024 using the keywords «microvascular decompression» and «hemifacial spasm». Only full-text articles in Russian, English, or French were included in the study. Results. Among 364 manuscripts, 24 met the inclusion criteria. The majority of studies demonstrated available experience and effectiveness of vascular decompression without description of surgical approach. Conclusion. Considering global experience, we proposed an optimal surgical algorithm, including initial dissection of bulbar nerves and facial nerve decompression, if possible, along its entire length.

16 October 2025 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
VSV.N. Shimansky
V.N. Shimansky
IKI.O. Kugushev
I.O. Kugushev
STS.V. Tanyashin
S.V. Tanyashin
MKM.V. Kolycheva
M.V. Kolycheva
VPV.K. Poshataev
V.K. Poshataev
VGV.A. Gorbulev
V.A. Gorbulev
Throughout history, physicians have attempted to alleviate suffering of patients with trigeminal neuralgia. However, treatment was ineffective because pathogenesis of disease was unclear. Nevertheless, history of neuralgia shows that pioneering observations made by experienced clinicians led to development of methods that at least partially alleviated pain despite unclear etiopathogenesis. Improvement of treatment methods has evolved from religious rituals to vascular decompression of trigeminal nerve.

16 October 2025 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
VSV.N. Shimansky
V.N. Shimansky
IKI.O. Kugushev
I.O. Kugushev
STS.V. Tanyashin
S.V. Tanyashin
MKM.V. Kolycheva
M.V. Kolycheva
VPV.K. Poshataev
V.K. Poshataev
VGV.A. Gorbulev
V.A. Gorbulev
Trigeminal neuralgia is a well-known disease characterized by excruciating, paroxysmal, piercing pain in the face. It is often provoked by facial expressions or eating. Physicians have attempted to describe this severe pain for the past two thousand years. They described cephalgia, but their descriptions were vague and did not correspond to what we now call trigeminal neuralgia. The first more precise description of trigeminal neuralgia was presented in the 17th century. However, pathogenesis was unclear for a long time. Only in the early 20th century, Walter Dandy suggested vascular compression of trigeminal root as a possible cause of disease.

30 November 2024 in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
Verified
Journal Article
Closed access
VSV. N. Shimansky
V. N. Shimansky
IKI. O. Kugushev
I. O. Kugushev
AKA. B. Kadasheva
A. B. Kadasheva
STS. V. Tanyashin
S. V. Tanyashin
VPV. K. Poshataev
V. K. Poshataev
RSR. A. Sadykov
R. A. Sadykov
An auditory nerve neurinoma is a benign tumor that usually occurs in the inner auditory canal in the Obersteiner — Redlich zone of the upper vestibular nerve between oligodendrocytes and Schwann cells located 8–10 mm from the pial membrane of the lateral surface of the bridge. The incidence is 1 case per 100,000 population per year. 90 % of infratentorial tumors in adults are neurinomas of the auditory nerve. The article provides data on the clinical picture, differential diagnosis and prevalence of this disease.